Immunology Market Anticipated Surpassing USD 240 Billion by 2035

Buy Now

An extensive study of propelling opportunities in, “Immunology Market Size, Share & Trends Analysis Report by Product Type (Antibodies (Monoclonal Antibodies (mAbs), Polyclonal Antibodies, Antibody Fragments, Others), Immunoassays (ELISA (Enzyme-Linked Immunosorbent Assay), Western Blot, Flow Cytometry, Immunofluorescence Assays, Others), Cytokines & Chemokines, Immunoglobulins, Checkpoint Inhibitors, Immune Cell Isolation Systems, Recombinant Proteins, Others), Technology, Disease Indication/Therapeutic Area, Test Type, Sample Type, Mode of Purchase, Setting/Point of Care, Modality/Treatment Approach, End-users and Geography (North America, Europe, Asia Pacific, Middle East, Africa, and South America) – Global Industry Data, Trends, and Forecasts, 2025–2035” A comprehensive report of growing market landscapes in the immunology sector uncovering key growth drivers including niche market leadership, technology-enabled distribution, and increasing consumer needs supporting immunology potential to scale globally.

Global Immunology Market Forecast 2035:

According to the report, the immunology market is anticipated to grow from USD 94.5 Billion in 2025 to USD 240.3 Billion in 2035 at a CAGR of 9.8% during the forecast. The immunology sector is experiencing solid growth due to an aging population in North America and Europe and growing investment in outpatient and virtual care models. There is increased collaboration between tech companies and healthcare providers in North America and Europe to advance telehealth and remote patient monitoring capabilities. Innovative training programs using virtual reality (VR) technology are being introduced to address caregiver shortages and enhance skills.

The use of AI-based care solutions is increasingly being adopted to support the delivery of personalized treatment and scalable services, in response to increasing demand in both developed and emerging economies. Additionally, a larger shift towards home-based care and remote options due to health-related changes from the pandemic are creating an additional growth mechanism for immunology care. Investments in security are also increasing, given the additional pool of health data being remotely collected from patients.

“Key Driver, Restraint, and Growth Opportunity Defining the Global Immunology Market”

The global immunology market is increasing because of the increasing incidence of autoimmune and chronic diseases, and the increased demand for convenient and patient-centric care in the home. Developments in telehealth, AI-powered monitoring, and digital health technologies are enhancing market growth by creating a platform for more personalized treatment and continuous remote care.

However, the growth of the market is limited by restrictive aspects, including little to no insurance reimbursement; workforce shortages related to home healthcare; and precursors that make it difficult for providers to monitor quality of care and safety. Issues concerning continuity of care will also limit growth.

Nevertheless, significant opportunities for growth exist in the intersection of innovative digital health and increased patient acceptance and preference for therapies delivered or monitored in the home. Ongoing investments into a healthcare infrastructure and replacing traditional methods with technology, will provide a base for the continued growth the market.

"Impact of Global Tariff Policies on the Global Immunology Market Growth and Strategy"

International tariffs affect the immunology market by raising the price of vital medical supplies and therapies. For example, tariffs can result in significantly higher prices if an immunology provider sources biologics, diagnostic products, or infusion devices from either China or Mexico. If the provider raises prices to address these higher costs, patient access to vital immunology treatment may be limited.

In order to address some of these supply-side challenges, companies are diversifying their supply chains or investing in domestic manufacturing to reduce reliance on off-shore production. In addition, many companies have incorporated various technologies to drive efficiencies in operation and ultimately reduce costs. Policymakers should also be aware of the effects of trade policy on affordability and access to healthcare when crafting tariff policies related to this market.

Expansion of Global Immunology Market

“Aging Demographics, Tech-Enabled Home Care, and Shift to Value-Based Models Accelerate Immunology Market Growth”

With the growing population of older adults with chronic and immune-related conditions, the need for accessible, at-home care is on the rise. Remote monitoring technologies, mobile health applications, and telehealth methods are advancing care even safer and more efficiently, outside typical clinical settings allowing patients to be cared for in their own home and reducing stress on already over-burdened hospitals.
Since, value-based care models gain traction, the healthcare system shifts its focus to outcomes and cost, creating opportunities for larger, home-based immunology services. While particularly applies to under-resourced areas and rural settings, these digital, affordable care solutions provide a timely opportunity to expand access to immunology services while improving long-term patient outcomes.

Regional Analysis of Global Immunology Market

The immunology market is witnessing steady growth across all major markets globally. In North America, particularly in the U.S. and Canada, there is continued growth in the home-based immunology market due to mature healthcare systems and insurance coverage. There has been a growing preference among patients for in-home treatment, and the structure is responding accordingly, with established reimbursement models and leverage to engage digital health solutions.
Europe is also home to many countries, such as Germany, the UK, and France, that have embraced home care services for some time and, with their established public healthcare systems, are contributing to stable market growth.
On the other hand, the Asia-Pacific market is experiencing some of the strongest growth in the immunology sector, particularly in countries like China, India, and Japan. These Asia-Pacific countries have large aging populations, increasing financial investment in healthcare, and increasing awareness of immune-related conditions. There is an increased preference among patients for the use of home-based care and personalized services, which will fuel demand for immunology in these countries moving forward as well.

Key players in the global immunology market include prominent companies such as Abbott Laboratories, AbbVie Inc., Agilent Technologies, Inc., Amgen Inc., bioMérieux SA, Bio-Rad Laboratories, Inc., Bristol-Myers Squibb, Danaher Corporation, Johnson & Johnson Innovative Medicine, Luminex Corporation, Merck & Co., Inc., Novartis AG, Ortho Clinical Diagnostics, PerkinElmer, Inc., Pfizer Inc., Qiagen N.V., Roche Holding AG, Siemens Healthineers, Thermo Fisher Scientific Inc., along with several other key players contributing to market growth through innovation, strategic partnerships, and global expansion.

The global immunology market has been segmented as follows:

Global Immunology Market Analysis, by Product Type

Antibodies
- Monoclonal Antibodies (mAbs)
- Polyclonal Antibodies
- Antibody Fragments
- Others
Immunoassays
- ELISA (Enzyme-Linked Immunosorbent Assay)
- Western Blot
- Flow Cytometry
- Immunofluorescence Assays
- Others
Cytokines & Chemokines
Immunoglobulins
Checkpoint Inhibitors
Immune Cell Isolation Systems
Recombinant Proteins
Others

Global Immunology Market Analysis, by Technology

Immunodiagnostics
Immunotherapy
Immunoproteomics
Immunogenetics
Immunoinformatics
Flow Cytometry
Multiplex Immunoassays
Single-Cell Analysis

Global Immunology Market Analysis, by Disease Indication/Therapeutic Area

Autoimmune Diseases
- Rheumatoid Arthritis
- Multiple Sclerosis
- Lupus
- Inflammatory Bowel Disease
- Psoriasis
- Others
Oncology/Cancer Immunology
Infectious Diseases
Transplant Rejection
Allergies & Asthma
Immunodeficiency Disorders

Global Immunology Market Analysis, by Test Type

Routine Immunology Tests
Specialized Immunology Tests
Autoimmune Disease Testing
Allergy Testing
Infectious Disease Serology
Transplant Immunology Testing

Global Immunology Market Analysis, by Sample Type

Blood/Serum/Plasma
Urine
Tissue Samples
Saliva
Cerebrospinal Fluid (CSF)
Synovial Fluid

Global Immunology Market Analysis, by Mode of Purchase

Direct Sales
Distributors
Online Platforms
Pharmacies
Hospital Pharmacies
Retail Pharmacies
Specialty Pharmacies

Global Immunology Market Analysis, by Setting/Point of Care

Laboratory-Based Testing
Point-of-Care Testing (POCT)
Home-Based Testing
Clinic-Based Testing

Global Immunology Market Analysis, by Modality/Treatment Approach

Immunosuppressants
Immunostimulants
Immunomodulators
Biologics
Small Molecules
Cell-Based Therapies
Gene Therapies

Global Immunology Market Analysis, by End-users

Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Laboratories
Academic & Research Institutions
Contract Research Organizations (CROs)
Blood Banks & Transfusion Centers
Forensic Laboratories
Others

Global Immunology Market Analysis, by Region

North America
Europe
Asia Pacific
Middle East
Africa
South America

About Us

MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.

Contact US

USA Address:

800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.

+1(302)303-2617

info@marketgenics.co

India Address:

3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.

sales@marketgenics.co

Table of Contents

1. Research Methodology and Assumptions
- 1.1. Definitions
- 1.2. Research Design and Approach
- 1.3. Data Collection Methods
- 1.4. Base Estimates and Calculations
- 1.5. Forecasting Models
  - 1.5.1. Key Forecast Factors & Impact Analysis
- 1.6. Secondary Research
  - 1.6.1. Open Sources
  - 1.6.2. Paid Databases
  - 1.6.3. Associations
- 1.7. Primary Research
  - 1.7.1. Primary Sources
  - 1.7.2. Primary Interviews with Stakeholders across Ecosystem
2. Executive Summary
- 2.1. Global Immunology Market Outlook
  - 2.1.1. Global Immunology Market Size (Value - USD Bn), and Forecasts, 2021-2035
  - 2.1.2. Compounded Annual Growth Rate Analysis
  - 2.1.3. Growth Opportunity Analysis
  - 2.1.4. Segmental Share Analysis
  - 2.1.5. Geographical Share Analysis
- 2.2. Market Analysis and Facts
- 2.3. Supply-Demand Analysis
- 2.4. Competitive Benchmarking
- 2.5. Go-to- Market Strategy
  - 2.5.1. Customer/ End-use Industry Assessment
  - 2.5.2. Growth Opportunity Data, 2025-2035
    - 2.5.2.1. Regional Data
    - 2.5.2.2. Country Data
    - 2.5.2.3. Segmental Data
  - 2.5.3. Identification of Potential Market Spaces
  - 2.5.4. GAP Analysis
  - 2.5.5. Potential Attractive Price Points
  - 2.5.6. Prevailing Market Risks & Challenges
  - 2.5.7. Preferred Sales & Marketing Strategies
  - 2.5.8. Key Recommendations and Analysis
  - 2.5.9. A Way Forward
3. Industry Data and Premium Insights
- 3.1. Global Immunology Industry Overview, 2025
  - 3.1.1. Healthcare & Pharmaceutical Industry Ecosystem Analysis
  - 3.1.2. Key Trends for Healthcare & Pharmaceutical Industry
  - 3.1.3. Regional Distribution for Healthcare & Pharmaceutical Industry
- 3.2. Supplier Customer Data
- 3.3. Source Roadmap and Developments
- 3.4. Trade Analysis
  - 3.4.1. Import & Export Analysis, 2025
  - 3.4.2. Top Importing Countries
  - 3.4.3. Top Exporting Countries
- 3.5. Trump Tariff Impact Analysis
  - 3.5.1. Manufacturer
  - 3.5.2. Supply Chain
  - 3.5.3. End Consumer
- 3.6. Raw Material Analysis
4. Market Overview
- 4.1. Market Dynamics
  - 4.1.1. Drivers
    - 4.1.1.1. Patient-Centric Innovations and Tech-Driven Growth in Immunology Care
  - 4.1.2. Restraints
    - 4.1.2.1. Cost and Regulatory Challenges Hampering Growth in Emerging and Resource-Limited Markets
- 4.2. Key Trend Analysis
- 4.3. Regulatory Framework
  - 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
  - 4.3.2. Tariffs and Standards
  - 4.3.3. Impact Analysis of Regulations on the Market
- 4.4. Value Chain Analysis
  - 4.4.1. Raw Components Sourcing
  - 4.4.2. Manufacturing and Processing
  - 4.4.3. Wholesalers/ E-commerce Platform
  - 4.4.4. End-use/ Customers
- 4.5. Cost Structure Analysis
  - 4.5.1. Parameter’s Share for Cost Associated
  - 4.5.2. COGP vs COGS
  - 4.5.3. Profit Margin Analysis
- 4.6. Pricing Analysis
  - 4.6.1. Regional Pricing Analysis
  - 4.6.2. Segmental Pricing Trends
  - 4.6.3. Factors Influencing Pricing
- 4.7. Porter’s Five Forces Analysis
- 4.8. PESTEL Analysis
- 4.9. Global Immunology Market Demand
  - 4.9.1. Historical Market Size – (Value - USD Bn), 2021-2024
  - 4.9.2. Current and Future Market Size – (Value - USD Bn), 2025–2035
    - 4.9.2.1. Y-o-Y Growth Trends
    - 4.9.2.2. Absolute $ Opportunity Assessment
5. Competition Landscape
- 5.1. Competition structure
  - 5.1.1. Fragmented v/s consolidated
- 5.2. Company Share Analysis, 2025
  - 5.2.1. Global Company Market Share
  - 5.2.2. By Region
    - 5.2.2.1. North America
    - 5.2.2.2. Europe
    - 5.2.2.3. Asia Pacific
    - 5.2.2.4. Middle East
    - 5.2.2.5. Africa
    - 5.2.2.6. South America
- 5.3. Product Comparison Matrix
  - 5.3.1. Specifications
  - 5.3.2. Market Positioning
  - 5.3.3. Pricing
6. Global Immunology Market Analysis, by Product Type
- 6.1. Key Segment Analysis
- 6.2. Global Immunology Market Size (Value - USD Bn), Analysis, and Forecasts, by Product Type, 2021-2035
  - 6.2.1. Antibodies
    - 6.2.1.1. Monoclonal Antibodies (mAbs)
    - 6.2.1.2. Polyclonal Antibodies
    - 6.2.1.3. Antibody Fragments
    - 6.2.1.4. Others
  - 6.2.2. Immunoassays
    - 6.2.2.1. ELISA (Enzyme-Linked Immunosorbent Assay)
    - 6.2.2.2. Western Blot
    - 6.2.2.3. Flow Cytometry
    - 6.2.2.4. Immunofluorescence Assays
    - 6.2.2.5. Others
  - 6.2.3. Cytokines & Chemokines
  - 6.2.4. Immunoglobulins
  - 6.2.5. Checkpoint Inhibitors
  - 6.2.6. Immune Cell Isolation Systems
  - 6.2.7. Recombinant Proteins
  - 6.2.8. Others
7. Global Immunology Market Analysis, by Technology
- 7.1. Key Segment Analysis
- 7.2. Global Immunology Market Size (Value - USD Bn), Analysis, and Forecasts, by Technology, 2021-2035
  - 7.2.1. Immunodiagnostics
  - 7.2.2. Immunotherapy
  - 7.2.3. Immunoproteomics
  - 7.2.4. Immunogenetics
  - 7.2.5. Immunoinformatics
  - 7.2.6. Flow Cytometry
  - 7.2.7. Multiplex Immunoassays
  - 7.2.8. Single-Cell Analysis
8. Global Immunology Market Analysis, by Disease Indication/Therapeutic Area
- 8.1. Key Segment Analysis
- 8.2. Global Immunology Market Size (Value - USD Bn), Analysis, and Forecasts, by Disease Indication/Therapeutic Area, 2021-2035
  - 8.2.1. Autoimmune Diseases
    - 8.2.1.1. Rheumatoid Arthritis
    - 8.2.1.2. Multiple Sclerosis
    - 8.2.1.3. Lupus
    - 8.2.1.4. Inflammatory Bowel Disease
    - 8.2.1.5. Psoriasis
    - 8.2.1.6. Others
  - 8.2.2. Oncology/Cancer Immunology
  - 8.2.3. Infectious Diseases
  - 8.2.4. Transplant Rejection
  - 8.2.5. Allergies & Asthma
  - 8.2.6. Immunodeficiency Disorders
9. Global Immunology Market Analysis, by Test Type
- 9.1. Key Segment Analysis
- 9.2. Global Immunology Market Size (Value - USD Bn), Analysis, and Forecasts, by Test Type, 2021-2035
  - 9.2.1. Routine Immunology Tests
  - 9.2.2. Specialized Immunology Tests
  - 9.2.3. Autoimmune Disease Testing
  - 9.2.4. Allergy Testing
  - 9.2.5. Infectious Disease Serology
  - 9.2.6. Transplant Immunology Testing
10. Global Immunology Market Analysis, by Sample Type
- 10.1. Key Segment Analysis
- 10.2. Global Immunology Market Size (Value - USD Bn), Analysis, and Forecasts, by Sample Type, 2021-2035
  - 10.2.1. Blood/Serum/Plasma
  - 10.2.2. Urine
  - 10.2.3. Tissue Samples
  - 10.2.4. Saliva
  - 10.2.5. Cerebrospinal Fluid (CSF)
  - 10.2.6. Synovial Fluid
11. Global Immunology Market Analysis, by Mode of Purchase
- 11.1. Key Segment Analysis
- 11.2. Global Immunology Market Size (Value - USD Bn), Analysis, and Forecasts, by Mode of Purchase, 2021-2035
  - 11.2.1. Direct Sales
  - 11.2.2. Distributors
  - 11.2.3. Online Platforms
  - 11.2.4. Pharmacies
  - 11.2.5. Hospital Pharmacies
  - 11.2.6. Retail Pharmacies
  - 11.2.7. Specialty Pharmacies
12. Global Immunology Market Analysis, by Setting/Point of Care
- 12.1. Key Segment Analysis
- 12.2. Global Immunology Market Size (Value - USD Bn), Analysis, and Forecasts, by Setting/Point of Care, 2021-2035
  - 12.2.1. Laboratory-Based Testing
  - 12.2.2. Point-of-Care Testing (POCT)
  - 12.2.3. Home-Based Testing
  - 12.2.4. Clinic-Based Testing
13. Global Immunology Market Analysis, by Modality/Treatment Approach
- 13.1. Key Segment Analysis
- 13.2. Global Immunology Market Size (Value - USD Bn), Analysis, and Forecasts, by Modality/Treatment Approach, 2021-2035
  - 13.2.1. Immunosuppressants
  - 13.2.2. Immunostimulants
  - 13.2.3. Immunomodulators
  - 13.2.4. Biologics
  - 13.2.5. Small Molecules
  - 13.2.6. Cell-Based Therapies
  - 13.2.7. Gene Therapies
14. Global Immunology Market Analysis, by End-users
- 14.1. Key Segment Analysis
- 14.2. Global Immunology Market Size (Value - USD Bn), Analysis, and Forecasts, by End-users, 2021-2035
  - 14.2.1. Pharmaceutical & Biotechnology Companies
  - 14.2.2. Hospitals & Diagnostic Laboratories
  - 14.2.3. Academic & Research Institutions
  - 14.2.4. Contract Research Organizations (CROs)
  - 14.2.5. Blood Banks & Transfusion Centers
  - 14.2.6. Forensic Laboratories
  - 14.2.7. Others
15. Global Immunology Market Analysis and Forecasts, by Region
- 15.1. Key Findings
- 15.2. Global Immunology Market Size (Value - USD Bn), Analysis, and Forecasts, by Region, 2021-2035
  - 15.2.1. North America
  - 15.2.2. Europe
  - 15.2.3. Asia Pacific
  - 15.2.4. Middle East
  - 15.2.5. Africa
  - 15.2.6. South America
16. North America Global Immunology Market Analysis
- 16.1. Key Segment Analysis
- 16.2. Regional Snapshot
- 16.3. North America Global Immunology Market Size (Value - USD Bn), Analysis, and Forecasts, 2021-2035
  - 16.3.1. Product Type
  - 16.3.2. Technology
  - 16.3.3. Disease Indication/Therapeutic Area
  - 16.3.4. Test Type
  - 16.3.5. Sample Type
  - 16.3.6. Mode of Purchase
  - 16.3.7. Setting/Point of Care
  - 16.3.8. Modality/Treatment Approach
  - 16.3.9. End-users
  - 16.3.10. Country
    - 16.3.10.1. USA
    - 16.3.10.2. Canada
    - 16.3.10.3. Mexico
- 16.4. USA Global Immunology Market
  - 16.4.1. Country Segmental Analysis
  - 16.4.2. Product Type
  - 16.4.3. Technology
  - 16.4.4. Disease Indication/Therapeutic Area
  - 16.4.5. Test Type
  - 16.4.6. Sample Type
  - 16.4.7. Mode of Purchase
  - 16.4.8. Setting/Point of Care
  - 16.4.9. Modality/Treatment Approach
  - 16.4.10. End-users
- 16.5. Canada Global Immunology Market
  - 16.5.1. Country Segmental Analysis
  - 16.5.2. Product Type
  - 16.5.3. Technology
  - 16.5.4. Disease Indication/Therapeutic Area
  - 16.5.5. Test Type
  - 16.5.6. Sample Type
  - 16.5.7. Mode of Purchase
  - 16.5.8. Setting/Point of Care
  - 16.5.9. Modality/Treatment Approach
  - 16.5.10. End-users
- 16.6. Mexico Global Immunology Market
  - 16.6.1. Country Segmental Analysis
  - 16.6.2. Product Type
  - 16.6.3. Technology
  - 16.6.4. Disease Indication/Therapeutic Area
  - 16.6.5. Test Type
  - 16.6.6. Sample Type
  - 16.6.7. Mode of Purchase
  - 16.6.8. Setting/Point of Care
  - 16.6.9. Modality/Treatment Approach
  - 16.6.10. End-users
17. Europe Global Immunology Market Analysis
- 17.1. Key Segment Analysis
- 17.2. Regional Snapshot
- 17.3. Europe Global Immunology Market Size (Value - USD Bn), Analysis, and Forecasts, 2021-2035
  - 17.3.1. Product Type
  - 17.3.2. Technology
  - 17.3.3. Disease Indication/Therapeutic Area
  - 17.3.4. Test Type
  - 17.3.5. Sample Type
  - 17.3.6. Mode of Purchase
  - 17.3.7. Setting/Point of Care
  - 17.3.8. Modality/Treatment Approach
  - 17.3.9. End-users
  - 17.3.10. Country
    - 17.3.10.1. Germany
    - 17.3.10.2. United Kingdom
    - 17.3.10.3. France
    - 17.3.10.4. Italy
    - 17.3.10.5. Spain
    - 17.3.10.6. Netherlands
    - 17.3.10.7. Nordic Countries
    - 17.3.10.8. Poland
    - 17.3.10.9. Russia & CIS
    - 17.3.10.10. Rest of Europe
- 17.4. Germany Global Immunology Market
  - 17.4.1. Country Segmental Analysis
  - 17.4.2. Product Type
  - 17.4.3. Technology
  - 17.4.4. Disease Indication/Therapeutic Area
  - 17.4.5. Test Type
  - 17.4.6. Sample Type
  - 17.4.7. Mode of Purchase
  - 17.4.8. Setting/Point of Care
  - 17.4.9. Modality/Treatment Approach
  - 17.4.10. End-users
- 17.5. United Kingdom Global Immunology Market
  - 17.5.1. Country Segmental Analysis
  - 17.5.2. Product Type
  - 17.5.3. Technology
  - 17.5.4. Disease Indication/Therapeutic Area
  - 17.5.5. Test Type
  - 17.5.6. Sample Type
  - 17.5.7. Mode of Purchase
  - 17.5.8. Setting/Point of Care
  - 17.5.9. Modality/Treatment Approach
  - 17.5.10. End-users
- 17.6. France Global Immunology Market
  - 17.6.1. Country Segmental Analysis
  - 17.6.2. Product Type
  - 17.6.3. Technology
  - 17.6.4. Disease Indication/Therapeutic Area
  - 17.6.5. Test Type
  - 17.6.6. Sample Type
  - 17.6.7. Mode of Purchase
  - 17.6.8. Setting/Point of Care
  - 17.6.9. Modality/Treatment Approach
  - 17.6.10. End-users
- 17.7. Italy Global Immunology Market
  - 17.7.1. Country Segmental Analysis
  - 17.7.2. Product Type
  - 17.7.3. Technology
  - 17.7.4. Disease Indication/Therapeutic Area
  - 17.7.5. Test Type
  - 17.7.6. Sample Type
  - 17.7.7. Mode of Purchase
  - 17.7.8. Setting/Point of Care
  - 17.7.9. Modality/Treatment Approach
  - 17.7.10. End-users
- 17.8. Spain Global Immunology Market
  - 17.8.1. Country Segmental Analysis
  - 17.8.2. Product Type
  - 17.8.3. Technology
  - 17.8.4. Disease Indication/Therapeutic Area
  - 17.8.5. Test Type
  - 17.8.6. Sample Type
  - 17.8.7. Mode of Purchase
  - 17.8.8. Setting/Point of Care
  - 17.8.9. Modality/Treatment Approach
  - 17.8.10. End-users
- 17.9. Netherlands Global Immunology Market
  - 17.9.1. Country Segmental Analysis
  - 17.9.2. Product Type
  - 17.9.3. Technology
  - 17.9.4. Disease Indication/Therapeutic Area
  - 17.9.5. Test Type
  - 17.9.6. Sample Type
  - 17.9.7. Mode of Purchase
  - 17.9.8. Setting/Point of Care
  - 17.9.9. Modality/Treatment Approach
  - 17.9.10. End-users
- 17.10. Nordic Countries Global Immunology Market
  - 17.10.1. Country Segmental Analysis
  - 17.10.2. Product Type
  - 17.10.3. Technology
  - 17.10.4. Disease Indication/Therapeutic Area
  - 17.10.5. Test Type
  - 17.10.6. Sample Type
  - 17.10.7. Mode of Purchase
  - 17.10.8. Setting/Point of Care
  - 17.10.9. Modality/Treatment Approach
  - 17.10.10. End-users
- 17.11. Poland Global Immunology Market
  - 17.11.1. Country Segmental Analysis
  - 17.11.2. Product Type
  - 17.11.3. Technology
  - 17.11.4. Disease Indication/Therapeutic Area
  - 17.11.5. Test Type
  - 17.11.6. Sample Type
  - 17.11.7. Mode of Purchase
  - 17.11.8. Setting/Point of Care
  - 17.11.9. Modality/Treatment Approach
  - 17.11.10. End-users
- 17.12. Russia & CIS Global Immunology Market
  - 17.12.1. Country Segmental Analysis
  - 17.12.2. Product Type
  - 17.12.3. Technology
  - 17.12.4. Disease Indication/Therapeutic Area
  - 17.12.5. Test Type
  - 17.12.6. Sample Type
  - 17.12.7. Mode of Purchase
  - 17.12.8. Setting/Point of Care
  - 17.12.9. Modality/Treatment Approach
  - 17.12.10. End-users
- 17.13. Rest of Europe Global Immunology Market
  - 17.13.1. Country Segmental Analysis
  - 17.13.2. Product Type
  - 17.13.3. Technology
  - 17.13.4. Disease Indication/Therapeutic Area
  - 17.13.5. Test Type
  - 17.13.6. Sample Type
  - 17.13.7. Mode of Purchase
  - 17.13.8. Setting/Point of Care
  - 17.13.9. Modality/Treatment Approach
  - 17.13.10. End-users
18. Asia Pacific Global Immunology Market Analysis
- 18.1. Key Segment Analysis
- 18.2. Regional Snapshot
- 18.3. East Asia Global Immunology Market Size (Value - USD Bn), Analysis, and Forecasts, 2021-2035
  - 18.3.1. Product Type
  - 18.3.2. Technology
  - 18.3.3. Disease Indication/Therapeutic Area
  - 18.3.4. Test Type
  - 18.3.5. Sample Type
  - 18.3.6. Mode of Purchase
  - 18.3.7. Setting/Point of Care
  - 18.3.8. Modality/Treatment Approach
  - 18.3.9. End-users
  - 18.3.10. Country
    - 18.3.10.1. China
    - 18.3.10.2. India
    - 18.3.10.3. Japan
    - 18.3.10.4. South Korea
    - 18.3.10.5. Australia and New Zealand
    - 18.3.10.6. Indonesia
    - 18.3.10.7. Malaysia
    - 18.3.10.8. Thailand
    - 18.3.10.9. Vietnam
    - 18.3.10.10. Rest of Asia-Pacific
- 18.4. China Global Immunology Market
  - 18.4.1. Country Segmental Analysis
  - 18.4.2. Product Type
  - 18.4.3. Technology
  - 18.4.4. Disease Indication/Therapeutic Area
  - 18.4.5. Test Type
  - 18.4.6. Sample Type
  - 18.4.7. Mode of Purchase
  - 18.4.8. Setting/Point of Care
  - 18.4.9. Modality/Treatment Approach
  - 18.4.10. End-users
- 18.5. India Global Immunology Market
  - 18.5.1. Country Segmental Analysis
  - 18.5.2. Product Type
  - 18.5.3. Technology
  - 18.5.4. Disease Indication/Therapeutic Area
  - 18.5.5. Test Type
  - 18.5.6. Sample Type
  - 18.5.7. Mode of Purchase
  - 18.5.8. Setting/Point of Care
  - 18.5.9. Modality/Treatment Approach
  - 18.5.10. End-users
- 18.6. Japan Global Immunology Market
  - 18.6.1. Country Segmental Analysis
  - 18.6.2. Product Type
  - 18.6.3. Technology
  - 18.6.4. Disease Indication/Therapeutic Area
  - 18.6.5. Test Type
  - 18.6.6. Sample Type
  - 18.6.7. Mode of Purchase
  - 18.6.8. Setting/Point of Care
  - 18.6.9. Modality/Treatment Approach
  - 18.6.10. End-users
- 18.7. South Korea Global Immunology Market
  - 18.7.1. Country Segmental Analysis
  - 18.7.2. Product Type
  - 18.7.3. Technology
  - 18.7.4. Disease Indication/Therapeutic Area
  - 18.7.5. Test Type
  - 18.7.6. Sample Type
  - 18.7.7. Mode of Purchase
  - 18.7.8. Setting/Point of Care
  - 18.7.9. Modality/Treatment Approach
  - 18.7.10. End-users
- 18.8. Australia and New Zealand Global Immunology Market
  - 18.8.1. Country Segmental Analysis
  - 18.8.2. Product Type
  - 18.8.3. Technology
  - 18.8.4. Disease Indication/Therapeutic Area
  - 18.8.5. Test Type
  - 18.8.6. Sample Type
  - 18.8.7. Mode of Purchase
  - 18.8.8. Setting/Point of Care
  - 18.8.9. Modality/Treatment Approach
  - 18.8.10. End-users
- 18.9. Indonesia Global Immunology Market
  - 18.9.1. Country Segmental Analysis
  - 18.9.2. Product Type
  - 18.9.3. Technology
  - 18.9.4. Disease Indication/Therapeutic Area
  - 18.9.5. Test Type
  - 18.9.6. Sample Type
  - 18.9.7. Mode of Purchase
  - 18.9.8. Setting/Point of Care
  - 18.9.9. Modality/Treatment Approach
  - 18.9.10. End-users
- 18.10. Malaysia Global Immunology Market
  - 18.10.1. Country Segmental Analysis
  - 18.10.2. Product Type
  - 18.10.3. Technology
  - 18.10.4. Disease Indication/Therapeutic Area
  - 18.10.5. Test Type
  - 18.10.6. Sample Type
  - 18.10.7. Mode of Purchase
  - 18.10.8. Setting/Point of Care
  - 18.10.9. Modality/Treatment Approach
  - 18.10.10. End-users
- 18.11. Thailand Global Immunology Market
  - 18.11.1. Country Segmental Analysis
  - 18.11.2. Product Type
  - 18.11.3. Technology
  - 18.11.4. Disease Indication/Therapeutic Area
  - 18.11.5. Test Type
  - 18.11.6. Sample Type
  - 18.11.7. Mode of Purchase
  - 18.11.8. Setting/Point of Care
  - 18.11.9. Modality/Treatment Approach
  - 18.11.10. End-users
- 18.12. Vietnam Global Immunology Market
  - 18.12.1. Country Segmental Analysis
  - 18.12.2. Product Type
  - 18.12.3. Technology
  - 18.12.4. Disease Indication/Therapeutic Area
  - 18.12.5. Test Type
  - 18.12.6. Sample Type
  - 18.12.7. Mode of Purchase
  - 18.12.8. Setting/Point of Care
  - 18.12.9. Modality/Treatment Approach
  - 18.12.10. End-users
- 18.13. Rest of Asia Pacific Global Immunology Market
  - 18.13.1. Country Segmental Analysis
  - 18.13.2. Product Type
  - 18.13.3. Technology
  - 18.13.4. Disease Indication/Therapeutic Area
  - 18.13.5. Test Type
  - 18.13.6. Sample Type
  - 18.13.7. Mode of Purchase
  - 18.13.8. Setting/Point of Care
  - 18.13.9. Modality/Treatment Approach
  - 18.13.10. End-users
19. Middle East Global Immunology Market Analysis
- 19.1. Key Segment Analysis
- 19.2. Regional Snapshot
- 19.3. Middle East Global Immunology Market Size (Value - USD Bn), Analysis, and Forecasts, 2021-2035
  - 19.3.1. Product Type
  - 19.3.2. Technology
  - 19.3.3. Disease Indication/Therapeutic Area
  - 19.3.4. Test Type
  - 19.3.5. Sample Type
  - 19.3.6. Mode of Purchase
  - 19.3.7. Setting/Point of Care
  - 19.3.8. Modality/Treatment Approach
  - 19.3.9. End-users
  - 19.3.10. Country
    - 19.3.10.1. Turkey
    - 19.3.10.2. UAE
    - 19.3.10.3. Saudi Arabia
    - 19.3.10.4. Israel
    - 19.3.10.5. Rest of Middle East
- 19.4. Turkey Global Immunology Market
  - 19.4.1. Country Segmental Analysis
  - 19.4.2. Product Type
  - 19.4.3. Technology
  - 19.4.4. Disease Indication/Therapeutic Area
  - 19.4.5. Test Type
  - 19.4.6. Sample Type
  - 19.4.7. Mode of Purchase
  - 19.4.8. Setting/Point of Care
  - 19.4.9. Modality/Treatment Approach
  - 19.4.10. End-users
- 19.5. UAE Global Immunology Market
  - 19.5.1. Country Segmental Analysis
  - 19.5.2. Product Type
  - 19.5.3. Technology
  - 19.5.4. Disease Indication/Therapeutic Area
  - 19.5.5. Test Type
  - 19.5.6. Sample Type
  - 19.5.7. Mode of Purchase
  - 19.5.8. Setting/Point of Care
  - 19.5.9. Modality/Treatment Approach
  - 19.5.10. End-users
- 19.6. Saudi Arabia Global Immunology Market
  - 19.6.1. Country Segmental Analysis
  - 19.6.2. Product Type
  - 19.6.3. Technology
  - 19.6.4. Disease Indication/Therapeutic Area
  - 19.6.5. Test Type
  - 19.6.6. Sample Type
  - 19.6.7. Mode of Purchase
  - 19.6.8. Setting/Point of Care
  - 19.6.9. Modality/Treatment Approach
  - 19.6.10. End-users
- 19.7. Israel Global Immunology Market
  - 19.7.1. Country Segmental Analysis
  - 19.7.2. Product Type
  - 19.7.3. Technology
  - 19.7.4. Disease Indication/Therapeutic Area
  - 19.7.5. Test Type
  - 19.7.6. Sample Type
  - 19.7.7. Mode of Purchase
  - 19.7.8. Setting/Point of Care
  - 19.7.9. Modality/Treatment Approach
  - 19.7.10. End-users
- 19.8. Rest of Middle East Global Immunology Market
  - 19.8.1. Country Segmental Analysis
  - 19.8.2. Product Type
  - 19.8.3. Technology
  - 19.8.4. Disease Indication/Therapeutic Area
  - 19.8.5. Test Type
  - 19.8.6. Sample Type
  - 19.8.7. Mode of Purchase
  - 19.8.8. Setting/Point of Care
  - 19.8.9. Modality/Treatment Approach
  - 19.8.10. End-users
20. Africa Global Immunology Market Analysis
- 20.1. Key Segment Analysis
- 20.2. Regional Snapshot
- 20.3. Africa Global Immunology Market Size (Value - USD Bn), Analysis, and Forecasts, 2021-2035
  - 20.3.1. Product Type
  - 20.3.2. Technology
  - 20.3.3. Disease Indication/Therapeutic Area
  - 20.3.4. Test Type
  - 20.3.5. Sample Type
  - 20.3.6. Mode of Purchase
  - 20.3.7. Setting/Point of Care
  - 20.3.8. Modality/Treatment Approach
  - 20.3.9. End-users
  - 20.3.10. Country
    - 20.3.10.1. South Africa
    - 20.3.10.2. Egypt
    - 20.3.10.3. Nigeria
    - 20.3.10.4. Algeria
    - 20.3.10.5. Rest of Africa
- 20.4. South Africa Global Immunology Market
  - 20.4.1. Country Segmental Analysis
  - 20.4.2. Product Type
  - 20.4.3. Technology
  - 20.4.4. Disease Indication/Therapeutic Area
  - 20.4.5. Test Type
  - 20.4.6. Sample Type
  - 20.4.7. Mode of Purchase
  - 20.4.8. Setting/Point of Care
  - 20.4.9. Modality/Treatment Approach
  - 20.4.10. End-users
- 20.5. Egypt Global Immunology Market
  - 20.5.1. Country Segmental Analysis
  - 20.5.2. Product Type
  - 20.5.3. Technology
  - 20.5.4. Disease Indication/Therapeutic Area
  - 20.5.5. Test Type
  - 20.5.6. Sample Type
  - 20.5.7. Mode of Purchase
  - 20.5.8. Setting/Point of Care
  - 20.5.9. Modality/Treatment Approach
  - 20.5.10. End-users
- 20.6. Nigeria Global Immunology Market
  - 20.6.1. Country Segmental Analysis
  - 20.6.2. Product Type
  - 20.6.3. Technology
  - 20.6.4. Disease Indication/Therapeutic Area
  - 20.6.5. Test Type
  - 20.6.6. Sample Type
  - 20.6.7. Mode of Purchase
  - 20.6.8. Setting/Point of Care
  - 20.6.9. Modality/Treatment Approach
  - 20.6.10. End-users
- 20.7. Algeria Global Immunology Market
  - 20.7.1. Country Segmental Analysis
  - 20.7.2. Product Type
  - 20.7.3. Technology
  - 20.7.4. Disease Indication/Therapeutic Area
  - 20.7.5. Test Type
  - 20.7.6. Sample Type
  - 20.7.7. Mode of Purchase
  - 20.7.8. Setting/Point of Care
  - 20.7.9. Modality/Treatment Approach
  - 20.7.10. End-users
- 20.8. Rest of Africa Global Immunology Market
  - 20.8.1. Country Segmental Analysis
  - 20.8.2. Product Type
  - 20.8.3. Technology
  - 20.8.4. Disease Indication/Therapeutic Area
  - 20.8.5. Test Type
  - 20.8.6. Sample Type
  - 20.8.7. Mode of Purchase
  - 20.8.8. Setting/Point of Care
  - 20.8.9. Modality/Treatment Approach
  - 20.8.10. End-users
21. South America Global Immunology Market Analysis
- 21.1. Key Segment Analysis
- 21.2. Regional Snapshot
- 21.3. Central and South Africa Global Immunology Market Size (Value - USD Bn), Analysis, and Forecasts, 2021-2035
  - 21.3.1. Product Type
  - 21.3.2. Technology
  - 21.3.3. Disease Indication/Therapeutic Area
  - 21.3.4. Test Type
  - 21.3.5. Sample Type
  - 21.3.6. Mode of Purchase
  - 21.3.7. Setting/Point of Care
  - 21.3.8. Modality/Treatment Approach
  - 21.3.9. End-users
  - 21.3.10. Country
    - 21.3.10.1. Brazil
    - 21.3.10.2. Argentina
    - 21.3.10.3. Rest of South America
- 21.4. Brazil Global Immunology Market
  - 21.4.1. Country Segmental Analysis
  - 21.4.2. Product Type
  - 21.4.3. Technology
  - 21.4.4. Disease Indication/Therapeutic Area
  - 21.4.5. Test Type
  - 21.4.6. Sample Type
  - 21.4.7. Mode of Purchase
  - 21.4.8. Setting/Point of Care
  - 21.4.9. Modality/Treatment Approach
  - 21.4.10. End-users
- 21.5. Argentina Global Immunology Market
  - 21.5.1. Country Segmental Analysis
  - 21.5.2. Product Type
  - 21.5.3. Technology
  - 21.5.4. Disease Indication/Therapeutic Area
  - 21.5.5. Test Type
  - 21.5.6. Sample Type
  - 21.5.7. Mode of Purchase
  - 21.5.8. Setting/Point of Care
  - 21.5.9. Modality/Treatment Approach
  - 21.5.10. End-users
- 21.6. Rest of South America Global Immunology Market
  - 21.6.1. Country Segmental Analysis
  - 21.6.2. Product Type
  - 21.6.3. Technology
  - 21.6.4. Disease Indication/Therapeutic Area
  - 21.6.5. Test Type
  - 21.6.6. Sample Type
  - 21.6.7. Mode of Purchase
  - 21.6.8. Setting/Point of Care
  - 21.6.9. Modality/Treatment Approach
  - 21.6.10. End-users
22. Key Players/ Company Profile
- 22.1. Abbott Laboratories
  - 22.1.1. Company Details/ Overview
  - 22.1.2. Company Financials
  - 22.1.3. Key Customers and Competitors
  - 22.1.4. Business/ Industry Portfolio
  - 22.1.5. Product Portfolio/ Specification Details
  - 22.1.6. Pricing Data
  - 22.1.7. Strategic Overview
  - 22.1.8. Recent Developments
- 22.2. AbbVie Inc.
- 22.3. Agilent Technologies, Inc.
- 22.4. Amgen Inc.
- 22.5. bioMérieux SA
- 22.6. Bio-Rad Laboratories, Inc.
- 22.7. Bristol-Myers Squibb
- 22.8. Danaher Corporation
- 22.9. Johnson & Johnson Innovative Medicine
- 22.10. Luminex Corporation
- 22.11. Merck & Co., Inc.
- 22.12. Novartis AG
- 22.13. Ortho Clinical Diagnostics
- 22.14. PerkinElmer, Inc.
- 22.15. Pfizer Inc.
- 22.16. Qiagen N.V.
- 22.17. Roche Holding AG
- 22.18. Siemens Healthineers
- 22.19. Thermo Fisher Scientific Inc.
- 22.20. Other Key Players

Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography

Get PDF

PRICING DETAILS

Single-User Upto 2 Users - [PDF + Excel Only]

USD 4150

Multi-User Upto 10 Users - [PDF + Excel + PPT]

USD 5950

Enterprise-User Company-wide - [Report Pack + Benchmark + 6M Update]

USD 7750

Related Report

Discount On Multiple Reports

Where did We Help Most?

Custom Market Research Services

We will customise the research for you, in case the report listed above does not meet your requirements.

Get 10% Free Customisation